Oncolytics Biotech Inc (ONCY.O)

+ 收藏

资产负债表(Oncolytics Biotech Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231123112311231
原始币种 加拿大元加拿大元加拿大元加拿大元加拿大元加拿大元加拿大元加拿大元加拿大元加拿大元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见24,850,000.0029,603,000.0034,912,000.0039,981,000.0017,520,000.0015,872,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见4,935,000.003,156,000.003,261,000.005,356,000.006,644,000.004,591,000.00
 短期投资(元) --------6,831,000.0013,798,000.00
 流动资产其他项目(元) 会员可见会员可见会员可见会员可见848,000.00623,000.00----
 流动资产合计(元) 会员可见会员可见会员可见会员可见30,633,000.0033,382,000.0038,173,000.0045,337,000.0030,995,000.0034,261,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见430,000.00301,000.00282,000.00299,000.00318,000.00339,000.00
 预付款项及其他长期应收款非流动(元) --------227,000.00227,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见1,006,000.001,067,000.00365,000.00453,000.00426,000.00501,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见1,436,000.001,368,000.00647,000.00752,000.00971,000.001,067,000.00
总资产(元) 会员可见会员可见会员可见会员可见32,069,000.0034,750,000.0038,820,000.0046,089,000.0031,966,000.0035,328,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见225,000.00179,000.00133,000.00191,000.00133,000.00189,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见4,653,000.003,610,000.003,572,000.004,536,000.002,365,000.002,232,000.00
 衍生工具负债流动(元) ------200,000.005,198,000.00153,000.0048,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见1,259,000.00314,000.00332,000.0093,000.00--
 流动负债合计(元) 会员可见会员可见会员可见会员可见6,137,000.004,103,000.004,237,000.0010,018,000.002,651,000.002,469,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见891,000.00948,000.00290,000.00323,000.00346,000.00378,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见6,730,000.006,730,000.006,730,000.006,730,000.006,730,000.006,730,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见7,621,000.007,678,000.007,020,000.007,053,000.007,076,000.007,108,000.00
总负债(元) 会员可见会员可见会员可见会员可见13,758,000.0011,781,000.0011,257,000.0017,071,000.009,727,000.009,577,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见434,547,000.00432,507,000.00430,906,000.00428,826,000.00413,424,000.00409,412,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-460,153,000.00-452,897,000.00-446,003,000.00-442,054,000.00-432,129,000.00-424,688,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见722,000.00670,000.00544,000.00655,000.00554,000.00659,000.00
 归属于母公司股东权益其他项目(元) 会员可见会员可见会员可见会员可见43,195,000.0042,689,000.0042,116,000.0041,591,000.0040,390,000.0040,368,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见18,311,000.0022,969,000.0027,563,000.0029,018,000.0022,239,000.0025,751,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见18,311,000.0022,969,000.0027,563,000.0029,018,000.0022,239,000.0025,751,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见32,069,000.0034,750,000.0038,820,000.0046,089,000.0031,966,000.0035,328,000.00
公告日期 2025-08-082025-05-142025-03-072024-11-122024-08-012024-05-092024-03-122023-11-032023-08-142023-05-05
会计准则 国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则
审计意见
核数师

前瞻产业研究院